Comparison of the Effects of Agalsidase Alfa and Agalsidase Beta on Cultured Human Fabry Fibroblasts and Fabry Mice

Journal of Human Genetics - United Kingdom
doi 10.1007/s10038-005-0342-9
Full Text
Abstract

Available in full text

Categories
Genetics
Date
Authors
Publisher

Springer Nature

Related search

Psy23 - Agalsidase Alfa and Agalsidase Beta for Treatment of Fabry Disease

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Effectiveness of Long-Term Agalsidase Alfa Therapy in the Treatment of Fabry Nephropathy

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2012English

Biventricular Cardiomyopathy Improvement by Shifting Therapy From Agalsidase Alfa to Agalsidase Beta in Anderson-Fabry Disease (RCD Code: III-3B.2)

Journal of Rare Cardiovascular Diseases
Cardiovascular MedicineCardiology
2018English

Long-Term Dose-Dependent Agalsidase Effects on Kidney Histology in Fabry Disease

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2017English

Clinical Course of Patients With Fabry Disease Who Were Switched From Agalsidase-Β to Agalsidase-Α

Genetics in Medicine
MedicineGenetics
2014English

Letter Concerning “Enzyme Replacement Therapy in a Patient With Fabry Disease and the Development of IgE Antibodies Against Agalsidase Beta but Not Agalsidase Alpha”, by Tanaka Et Al.

Journal of Inherited Metabolic Disease
Genetics
2010English

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase Beta Therapy in Patients With Fabry Disease

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2007English

Fabry Disease

Revista de la Facultad de Medicina Humana
2018English

Characterization of Fabry Disease in 352 Pediatric Patients in the Fabry Registry

Pediatric Research
Child HealthPediatricsPerinatology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy